Explore

Capbase

Akari Therapeutics Plc — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Other Health Care

$1.8MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Akari Therapeutics Plc filed a Form D notice of exempt offering with the SEC.

1 rounds

No investors recorded yet for Akari Therapeutics Plc.

Leadership

Kameel FaragExecutive Officer · Interim Chief Financial OfficerSince 2026Source: [SEC]

Showing 2 of 8 — any approved contribution unlocks every profile for 30 days.Sign in to unlock

Akari Therapeutics Plc has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Akari Therapeutics Plc.

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.